<?xml version="1.0" encoding="UTF-8"?>
<p id="p0020">Despite the low fatality rate caused by Covid-19 compared with other earlier coronavirus epidemics produced by SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV), diabetic and obese people are at a high risk (
 <xref rid="bib71" ref-type="bibr">Yang et al., 2020</xref>). Recently, it has been reported that diabetes is an important risk factor for the progression and adverse outcome of Covid-19 and more attention must be paid to diabetic, obese, and hypertensive patients, particularly considering the rapid deterioration (
 <xref rid="bib9" ref-type="bibr">Bloomgarden, 2020</xref>; 
 <xref rid="bib31" ref-type="bibr">Guo et al., 2020</xref>). Therefore, adequate information about the relationship between Covid-19 and metabolic syndrome is required for better management of these patients.
</p>
